US Archives - Page 147 of 201 - European Medical Journal

Cognitive Activity in Midlife and Late Life Lowers Alzheimer’s Risk

Engaging in mentally stimulating activities in midlife and late life is linked to a lower risk of Alzheimer’s disease (AD), according to a study from the Chicago Health and Aging Project.

How To Better Guide Patient Management in Aggressive Lymphoma: New Data on PET/CT

18F-FDG PET and PET/CT scans show strong diagnostic accuracy in detecting histological transformations (HT) in indolent lymphomas, including Richter’s transformation (RT) in chronic lymphocytic leukemia (CLL), according to a new meta-analysis.

Pediatric CF Therapy Enhances Airway Function

A real-world study from the Netherlands has shared the benefits of lumacaftor/ivacaftor (lum/iva) in children with cystic fibrosis (CF) homozygous for the F508del mutation.

Cardiovascular Imaging Breakthroughs for Rheumatic Disease

A recent study evaluated the advantages and limitations of various noninvasive imaging modalities in diagnosing cardiovascular disease (CVD) in patients with autoimmune rheumatic diseases (ARDs).

Future of AI in Aesthetic Skin Care

Recent advancements in artificial intelligence (AI) are reshaping dermatology, particularly in diagnosing skin diseases like skin cancer.

Perinatal Lead Exposure Linked to Lower Vaccine Antibody Response

Emerging research highlights critical windows of susceptibility to lead exposure that may reduce antibody responses to childhood vaccines, raising concerns for immune health.

AI Tool Using Blood Tests Predicts Cancer Immunotherapy Success

A machine learning model, SCORPIO, has shown promise in predicting the success of immune checkpoint inhibitors (ICIs) for patients with cancer.

Semaglutide Cuts Alcohol Cravings in New Trial

A new randomized clinical trial suggests that once-weekly semaglutide may help reduce alcohol consumption and cravings in adults with alcohol use disorder (AUD).

NIH Funding Cuts Threaten U.S. Health

The National Institutes of Health (NIH) faces substantial funding cuts that could derail progress in critical medical research.

Glucose-Lowering Drugs Lower COPD Exacerbations

Sodium-glucose cotransporter-2 inhibitors (SGLT-2is) and glucagon-like peptide-1 receptor agonists (GLP-1RAs) may significantly reduce the risk of chronic obstructive pulmonary disease (COPD) exacerbations in patients with type 2 diabetes (T2D), according to a large U.S.-based study.